<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03114397</url>
  </required_header>
  <id_info>
    <org_study_id>2014/113b</org_study_id>
    <nct_id>NCT03114397</nct_id>
  </id_info>
  <brief_title>Long-term Effect of tDCS in Patients With Disorders of Consciousness</brief_title>
  <official_title>Long-term Effect of 20 Sessions of Transcranial Direct Current Stimulation in Patients With Disorders of Consciousness: a Double Blind Sham Controlled Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondazione Salvatore Maugeri, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universit√© Catholique de Louvain, Belgium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospitales Nisa, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>I.R.C.C.S. Fondazione Santa Lucia, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Schoen Clinic Bad Aibling, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Research Center of Neurology, Russia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Therapiezentrum Burgau, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>pavlov state medical university, Russia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Unita Sanitaria Locale di Piacenza, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Liege</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this multicentric double-blind sham controlled study, the investigators plan to assess the
      effects of 20 sessions of tDCS on long-term behavioral recovery in patients with disorders of
      consciousness. Neurophysiological outcomes (EEG) will also be collected.

      This research will 1) determine whether long-term behavioral recovery can be promoted with
      tDCS and 2) generate knowledge regarding the impact of tDCS on neurophysiological outcome
      (i.e., EEG) in severely brain injured patients. The investigators will compare the effects of
      active and sham tDCS on behavioral assessments and quantitative EEG in patients with severe
      brain injury and its potential application in rehabilitation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the CRS-R total score</measure>
    <time_frame>4 weeks</time_frame>
    <description>Improvement of the CRS-R total score after the end of the anodal session.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Disorder of Consciousness</condition>
  <arm_group>
    <arm_group_label>anodal stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive anodal tDCS (on the left dorsolateral prefrontal cortex) every day for 4 weeks, 5 days per week (tDCS of 2mA during 20minutes) for a total of 20 sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham stimulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive sham tDCS (on the left dorsolateral prefrontal cortex) every day for 4 weeks, 5 days per week (tDCS of 2mA during 20minutes) for a total of 20 sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation - active</intervention_name>
    <description>transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes.</description>
    <arm_group_label>anodal stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation - sham</intervention_name>
    <description>transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes. The sham intervention consists of 30 seconds of stimulation at the beginning and the end of the 20minutes of intervention.</description>
    <arm_group_label>sham stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CNS medication stable for at least a week

          -  Stable diagnosis (no diagnosis change based on 2 CRS-R performed within 1 week).

          -  Between 3 and 24 months post injury

          -  Structural MRI or CT-scan (to evidence focal lesions on the left DLPFC)

        Exclusion Criteria:

          -  Craniotomies encompassing the frontal region (electrodes location)

          -  VPS under the stimulated area (prefrontal cortex)

          -  Pacemaker

          -  Metallic cerebral implant

          -  Severe medical conditions that might influence clinical diagnosis and EEG activity
             (e.g., severe hepatic insufficiency or renal failure, or sub-continuous or abundant
             epileptiform discharges on standard EEG recordings).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aurore Thibaut, PhD</last_name>
    <phone>+32 4 366 24 44</phone>
    <email>athibaut@ulg.ac.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Liege</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurore Thibaut, PhD</last_name>
      <phone>003243668069</phone>
      <email>athibaut@ulg.ac.be</email>
    </contact>
    <contact_backup>
      <last_name>Geraldine Martens, MSc</last_name>
      <phone>00323668070</phone>
      <email>geraldine.martens@ulg.ac.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Thibaut A, Wannez S, Donneau AF, Chatelle C, Gosseries O, Bruno MA, Laureys S. Controlled clinical trial of repeated prefrontal tDCS in patients with chronic minimally conscious state. Brain Inj. 2017;31(4):466-474. doi: 10.1080/02699052.2016.1274776. Epub 2017 Mar 10.</citation>
    <PMID>28281845</PMID>
  </reference>
  <reference>
    <citation>Thibaut A, Bruno MA, Ledoux D, Demertzi A, Laureys S. tDCS in patients with disorders of consciousness: sham-controlled randomized double-blind study. Neurology. 2014 Apr 1;82(13):1112-8. doi: 10.1212/WNL.0000000000000260. Epub 2014 Feb 26.</citation>
    <PMID>24574549</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 29, 2017</study_first_submitted>
  <study_first_submitted_qc>April 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2017</study_first_posted>
  <last_update_submitted>March 9, 2020</last_update_submitted>
  <last_update_submitted_qc>March 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Liege</investigator_affiliation>
    <investigator_full_name>Aurore Thibaut</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Consciousness Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

